Banner

Robert Grand ’78 presented with IUPUI’s Spirit of Philanthropy Award

Robert ’78 and Melody Grand were recently presented with the IUPUI Spirit of Philanthropy Award.

Melody and Robert ’78 Grand

The Grands were recognized for having loyally supported the IU Robert H. McKinney School of Law and demonstrating the value of giving back to one’s alma mater.

Bob is a member of the law school’s Board of Visitors, according to a news release. The couple’s recent gifts have focused on an endowed chair and a memorial scholarship, created to recognize the excellence of the faculty and to help students who face financial challenges.

Bob graduated from Wabash College in 1978, where he majored in economics and was a member of Beta Theta Pi. He graduated from Indiana University Bloomington in 1978 with a degree in biological sciences and from IU McKinney Law in 1982.

Bob is the firm managing partner of Barnes & Thornburg and concentrates his practice in the areas of public finance and governmental regulation.


Scott Campbell ’14 joins Ambassador Enterprises

Scott Campbell

Scott Campbell ’14 has joined Ambassador Enterprises as Corporate Counsel. Based in Fort Wayne, Ambassador Enterprises is a private equity firm engaging with leaders and organizations committed to creating lasting, positive impact on people and communities.

“I’m excited to add Scott to our team,” Chief Legal Officer Jeremy Gayed said in a news release. “I’m confident that Scott’s unique combination of talent and humility will be a valuable addition to AE’s culture of care, performance, and responsible capitalism.”

Campbell comes to Ambassador Enterprises from the law firm of Barrett McNagny, LLP, where he served as an Associate in their Business Practice Group. He was most recently honored as a 2021 Best Lawyers in America: Ones to Watch.

“Ambassador Enterprises’ commitment to generating financial, cultural, and eternal returns in every investment truly makes it a special and rewarding place to grow as an individual and team member,” Campbell said. “I look forward to leveraging my experience to create effective transition plans for businesses and owners interested in sustaining their legacy, as well as partnering with other AE leaders focused on community impact, philanthropic partnering, and civic engagement.”

Campbell graduated from the University of Notre Dame Law School and received his undergraduate degree from Wabash College. At Wabash, he double majored in economics and Classics and was a member of Beta Theta Pi, Student Senate, Pre-Law Society, Interfraternity Council, and the Bachelor.


Kurt Snyder ’89 earns Inspiring Change Leadership Award

Kurt Snyder ’89, executive director of the Stanford Center for Continuing Medical Education, received the 2019-2020 Stanford University School of Medicine Inspiring Change Leadership Award.

Kurt Snyder

The award is given to a staff employee who has outstanding performance and have initiated or led change and innovation: implementing new processes, systems, organizational structures, or operating paradigms which will result in transformative improvements in service, efficiency, value, effectiveness, outcome, or satisfaction. The winner receives a $3,000 check.

As the executive director, Snyder advances patient outcomes via physician education on behalf of Stanford Medicine. He’s held this role since 2018.

“We appreciate all you do for our team, Stanford University and the community,” the Stanford CME Team said in a LinkedIn post. “We are lucky to have you!”

Prior to working at Standford University, Snyder worked as the Director of Continuing Medical Education at Indiana University School of Medicine and was an adjunct professor at Indiana University Kelley School of Business.

At Wabash, Snyder majored in history and minored in political science. He was a member of Phi Gamma Delta, Sphinx Club and the cross-country team.


Steven Pfanstiel ’95 hired as CFO for Marinus Pharmaceuticals

Steven Pfanstiel ’95 was recently hired as the Chief Financial Officer for Marinus Pharmaceuticals, Inc., a pharmaceutical company dedicated to the development of innovative therapeutics to treat rare seizure disorders.

Steven Pfanstiel

“Marinus is committed to making a significant difference in the lives of people touched by rare pediatric and refractory epilepsy,” Pfanstiel said in a news release. “The science is strong, and I am pleased to bring a strong financial discipline and foundation to support the company in its continued development activities and as it plans for commercialization of ganaxolone.”

Pfanstiel has a long track record in life sciences and pharmaceuticals, supporting the financial side of R&D, supply chain, and global commercialization organizations.

Before joining Marinus, Pfanstiel worked for 16 years in various divisions and operating companies of Johnson & Johnson.

He was most recently the Vice President of Finance for LifeScan of Malvern, a world leader in blood glucose monitoring known for its OneTouch brand products for managing diabetes, according to a news release. At LifeScan, he was responsible for a finance team of over 40 and drove significant cost savings while optimizing investment in sales and marketing.

Dr. Scott Braunstein, Chief Executive Officer of Marinus Pharmaceuticals, said Pfanstiel is a “stellar leader” who will be instrumental in positioning the company for its next phase of growth.

“(Pfanstiel) brings skills and seasoned expertise that will prove invaluable as we build our organization and prepare for potential commercial launch,” Braunstein said in a news release.

Pfanstiel majored in physics at Wabash College and was a member of Delta Tau Delta. He holds a M.S. in environmental systems engineering from Clemson University and an M.B.A. in finance from the Indiana University Kelley School of Business in Indianapolis.